🔎 Trials Near Me

Utama › Kanser Paru-paru › Indiana › Hammond

Kajian klinikal Kanser Paru-paru di Hammond, IN

10 kajian untuk Kanser Paru-paru sedang mencari peserta di lokasi dalam dan sekitar Hammond (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Mengambil pesertaFasa 3
  • The Community Hospital, Munster · 1 mi jauh
  • Women's Diagnostic Center - Munster, Munster · 1 mi jauh
  • Northwest Oncology LLC, Dyer · 6 mi jauh
  • dan 2 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04267848

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Ingalls Memorial Hospital, Harvey · 8 mi jauh
  • Advocate South Suburban Hospital, Hazel Crest · 10 mi jauh
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Mengambil pesertaFasa 3
  • The Community Hospital, Munster · 1 mi jauh
  • Women's Diagnostic Center - Munster, Munster · 1 mi jauh
  • Northwest Oncology LLC, Dyer · 6 mi jauh
  • dan 1 lagi
Umur 70 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Mengambil pesertaFasa 3
  • The Community Hospital, Munster · 1 mi jauh
  • Women's Diagnostic Center - Munster, Munster · 1 mi jauh
  • Northwest Oncology LLC, Dyer · 6 mi jauh
  • dan 1 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT04181060

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Mengambil pesertaFasa 2
  • Franciscan Health, Munster · 1 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07154290

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Mengambil pesertaFasa 3
  • The Community Hospital, Munster · 1 mi jauh
  • Women's Diagnostic Center - Munster, Munster · 1 mi jauh
  • Northwest Oncology LLC, Dyer · 6 mi jauh
  • dan 1 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT05624996

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2
  • Advocate South Suburban Hospital, Hazel Crest · 10 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Jun 2026 · NCT05642572

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2/3
  • Advocate South Suburban Hospital, Hazel Crest · 10 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Mei 2026 · NCT06616584

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Mengambil pesertaFasa 1/2
  • Northwest Cancer Centers, Dyer · 6 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Mac 2026 · NCT06244771

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

Mengambil pesertaKajian pemerhatian
  • Advocate South Suburban Hospital, Hazel Crest · 10 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Jan 2026 · NCT06073431

Kajian Kanser Paru-paru di bandar lain

Kajian lain di Hammond

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.